The Price of a Cure: Luxturna and the Economic Dilemmas of Precision Medicine. (PubMed, J Law Med Ethics) - Oct 8, 2026 - "Rather than simply controlling prices, the paper proposes a policy toolkit that includes amortizing payments over time, bundling diagnostics with drugs and insurance, and streamlining regulation to lower development costs. The aim is to preserve innovation while expanding patient access."
Journal • Gene Therapies
|